P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions - Wikidata - wikimedia - TriplyDB

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

http://www.wikidata.org/entity/Q27321418

about

Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation Purinergic signaling in epilepsy.

P2860

Q26774666-FA969D29-478B-4A52-8F68-530F9EA001A2 Q38865526-DBC47D1D-4FB5-49E3-9398-0B461E83A3D1

P2860

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

http://www.wikidata.org/entity/Q27321418

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

@ast

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

@en

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

@nl

type

label

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

@ast

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

@en

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

@nl

prefLabel

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

@ast

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

@en

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

@nl

P1433

Q27321418-F66F765A-E0FE-469B-BD34-4C78E51F00F6

P1476

Q27321418-04BAD565-1076-4D8A-851F-9E9645B566F9

P2093

Q27321418-0EA26E93-D265-41CA-B18C-4F7E0A669561

Q27321418-4ACD9A15-FD51-42A1-A7A1-0B5CDF074E7E

Q27321418-AD0ECBA4-12CE-45DC-9D8D-29D5400EC4DD

Q27321418-BFCAFDA1-1B2C-4E66-8046-FEDBF2885592

P2860

Q27321418-00471E32-B958-472A-B67D-58F35F0EB545

Q27321418-01CE551A-A01F-45C0-AF23-420931D4FD47

Q27321418-03352FC5-22C8-4234-BE4D-03C67333BECE

Q27321418-0339F7BB-8ABC-407C-A17D-B8B2A837A5D5

Q27321418-049A74F5-AC94-42AE-AA06-89BB994A4B42

Q27321418-05E35ADF-F6BB-4116-AA12-066A164788D8

Q27321418-08B5C09F-2B11-4AA9-85AD-20115A24674C

Q27321418-0ADD2144-33F7-48C0-82D2-258496C32EA7

Q27321418-11C7E76C-AD7A-4F3E-A890-F68D65D9B5B8

Q27321418-125EA759-E44A-447C-9791-2ED3D5792F64

P304

Q27321418-A4FF7396-F440-4CF1-BB55-05316C389B4E

P31

Q27321418-B7C63CA5-1CAB-4977-A2E5-2C14AF506120

P356

Q27321418-4BF40C71-A368-4566-B966-0C8309C492FD

P433

Q27321418-D442B7F5-8C68-41B5-A94B-58F2FB3A05FC

P478

Q27321418-DECA20F7-CFD2-4ACE-8662-EDC951DFD78D

P50

Q27321418-719E5F02-6076-4FE3-B061-8FFD34A419D1

P577

Q27321418-19CD2B8A-B459-4A20-9F29-821EF281F4A6

P698

Q27321418-19B1A10B-2630-416A-B558-E164B86E4875

P921

Q27321418-D832F9BA-0AAE-4064-AF70-DDE1A5836981

Q27321418-EA5AD815-6FC3-4080-9ECF-7F2586FA0F1E

P932

Q27321418-884EF9CE-B221-4BB0-B6A3-FB3EB8593760

P356

P1433

Journal of Virology

P1476

P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions

@en

P2093

Charline Giroud

http://www.w3.org/2001/XMLSchema#string

Gregory B Melikyan

http://www.w3.org/2001/XMLSchema#string

Mariana Marin

http://www.w3.org/2001/XMLSchema#string

Paul Spearman

http://www.w3.org/2001/XMLSchema#string

P2860

HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes

Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor

HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors

Cloning of a human heptahelical receptor closely related to the P2Y5 receptor

Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists

Signaling at purinergic P2X receptors

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene

P304

9368-9382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01178-15

http://www.w3.org/2001/XMLSchema#string

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26136569

http://www.w3.org/2001/XMLSchema#string

P921

membrane fusion involved in viral entry into host cell

P932

4542394

http://www.w3.org/2001/XMLSchema#string